E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/4/2005 in the Prospect News Biotech Daily.

Endocare secures $4 million line of credit from Silicon Valley Bank

By Angela McDaniels

Seattle, Nov. 4 - Endocare Inc. said it has secured a $4 million line of credit from Silicon Valley Bank, the primary subsidiary of SVB Financial Group.

"The credit line is a 12-month facility and will be used to provide additional working capital, as needed, to fund the company's growth," said Endocare chief financial officer Michael Rodriguez in a company press release.

Silicon Valley Bank is based in Santa Clara, Calif., and provides financial services to companies in the technology, life science, private equity and premium wine industries.

Endocare is based in Irvine, Calif., where it develops medical devices primarily for tissue and tumor ablation and erectile dysfunction.

Issuer:Endocare Inc.
Issue:Line of credit
Amount:$4 million
Maturity:November 2006
Lender:Silicon Valley Bank
Announcement date:Nov. 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.